Healthcare & Biotech

Forget Walgreens, Why Rite Aid (NYSE:RAD) Stock Is A Buy At $3

We added 10,000 additional shares of RAD stock when it fell 15%. Here’s why Rte Aid Corporaion (NYSE:RAD) is now a good investment

Also posted in Members, Mergers & Acquisitions, Timely Analysis, Uncategorized | | Tagged , , , | 1 Comment

Why ACADIA Pharmaceuticals Inc (NASDAQ:ACAD) Stock Is A Buy Near $25

Will ACAD stock reverse ahead of a breakout year from Nuplazid and ACADIA Pharmaceuticals Inc (NASDAQ:ACAD)? Or will Acadia stock go lower?

Also posted in Members | | Tagged , | 1 Comment

The Real Reason Regulators Are Blocking Walgreens Rite Aid Merger (WBA) (RAD)

Regulators want to avoid another Dollar Tree Family Dollar debacle with the Walgreens Rite Aid merger. Would be best for RAD stock.

Also posted in HADE Platform, Members | | Tagged , , , , , | 3 Comments

TG Therapeutics (NASDAQ:TGTX) stock to retest $15 with TG-1101 data ahead

TGTX stock jumped 15% before ASCO presentation of TG-1101. This move was not by mistake, best years for TG Therapeutics (NASDAQ:TGTX) to come.

Also posted in Hot Stocks, Members | | Tagged , | Leave a comment

3 Catalysts For Amgen, Inc (NASDAQ:AMGN) Stock

Two drugs could very well take AMGN stock from being dead money to big gains, making Amgen, Inc (NASDAQ:AMGN) a good investment once more.

Also posted in HADE Platform | | Tagged , | Leave a comment

How Valeant Pharmaceuticals can unlock 300% gains in VRX stock

By divesting B&L and Salix, Valeant Pharmaceuticals could unlock gains of 300% in VRX stock. Here’s why Valeant stock owners should welcome the deal.

Also posted in HADE Platform, Members | | Tagged , | 2 Comments

3 reasons Celgene Corporation (NASDAQ:CELG) stock owners should not worry about Revlimid

Revlimid sales will remains a catalyst for CELG stock and a big part of Celgene Corporation’s (NASDAQ:CELG) outlook, but there’s more to Celgene stock.

Also posted in HADE Platform, Members | | Tagged , | Leave a comment